Evaluating the Role of Methylated Circulating Tumor DNA in Combination With Pathological Prognostic Factors for Predicting Recurrence of Colorectal Cancer.
Hiba Al NajiJean M WinterSusanne K PedersenAmitesh RoySusan E ByrneGraeme P YoungErin Leigh SymondsPublished in: Biomarker insights (2024)
Australian and New Zealand Clinical Trials Registry #12611000318987.